Identifying Novel ATX Inhibitors via Combinatory Virtual Screening Using Crystallography-Derived Pharmacophore Modelling, Docking Study, and QSAR Analysis

Molecules. 2020 Mar 2;25(5):1107. doi: 10.3390/molecules25051107.

Abstract

Autotaxin (ATX) is considered as an interesting drug target for the therapy of several diseases. The goal of the research was to detect new ATX inhibitors which have novel scaffolds by using virtual screening. First, based on two diverse receptor-ligand complexes, 14 pharmacophore models were developed, and the 14 models were verified through a big test database. Those pharmacophore models were utilized to accomplish virtual screening. Next, for the purpose of predicting the probable binding poses of compounds and then carrying out further virtual screening, docking-based virtual screening was performed. Moreover, an excellent 3D QSAR model was established, and 3D QSAR-based virtual screening was applied for predicting the activity values of compounds which got through the above two-round screenings. A correlation coefficient r2, which equals 0.988, was supplied by the 3D QSAR model for the training set, and the correlation coefficient r2 equaling 0.808 for the test set means that the developed 3D QSAR model is an excellent model. After the filtering was done by the combinatory virtual screening, which is based on the pharmacophore modelling, docking study, and 3D QSAR modelling, we chose nine potent inhibitors with novel scaffolds finally. Furthermore, two potent compounds have been particularly discussed.

Keywords: 3D QSAR model; autotaxin inhibitor; docking calculation; pharmacophore model; virtual screening.

MeSH terms

  • Drug Evaluation, Preclinical
  • Humans
  • Molecular Docking Simulation*
  • Phosphodiesterase Inhibitors / chemistry*
  • Phosphoric Diester Hydrolases / chemistry*
  • Quantitative Structure-Activity Relationship

Substances

  • Phosphodiesterase Inhibitors
  • Phosphoric Diester Hydrolases
  • alkylglycerophosphoethanolamine phosphodiesterase